Deployment of dedicated nursing staff to stimulate use of clozapine.
- Registration Number
- NL-OMON20244
- Lead Sponsor
- Rivierduinen, GGZ Leiden, the Netherlands and Maastricht University, the Netherlands.
- Brief Summary
one yet
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 16
Inclusion Criteria
Teams:
- Outpatient teams in which a nurse practitioner participates
Patients:
Exclusion Criteria
NA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1a. Proportion of missed weekly lab exams (white blood cells) in condition A vs. B. <br /><br>1b. Number of days the lab exams (white blood cells) are delayed, divided by total number of required lab exams in condition A vs. B. <br /><br>
- Secondary Outcome Measures
Name Time Method 1. Duration of clozapine use in condition A vs. B.<br><br /><br>2. Clinical Global Impression-Schizophrenia scale (CGI-SCH) score of change in condition A vs. B.<br><br /><br>3. Proportion of patients indicated for clozapine (in condition A vs. B) who actually start with this drug.<br><br /><br>4. Proportion of patients for whom clozapine is indicated.<br><br /><br>5. Qualitative data to explore how potentially hazardous side-effects were handled. <br /><br>